Matthew Shields, Executive Vice President, Global Operations, on June 18, 2026, sold 9,989 shares in Teva Pharmaceutical Industries (TEVA) for $321,547.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/818686/000119312526277490/xslF345X05/ownership.xml